RJFSA
GBT

Raymond James Financial Services Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,493
Closed -$248K – 3119
2020
Q3 		$248K Buy
4,493
+146
+3% +$9.28K ﹤0.01% 2400
2020
Q2 		$274K Sell
4,347
-875
-17% -$60K ﹤0.01% 2286
2020
Q1 		$267K Sell
5,222
-400
-7% -$26.8K ﹤0.01% 1911
2019
Q4 		$447K Sell
5,622
-325
-5% -$19.3K ﹤0.01% 2057
2019
Q3 		$289K Buy
5,947
+510
+9% +$26.6K ﹤0.01% 2272
2019
Q2 		$286K Sell
5,437
-3,850
-41% -$221K ﹤0.01% 2299
2019
Q1 		$492K Sell
9,287
-1,238
-12% -$60.8K ﹤0.01% 1910
2018
Q4 		$432K Buy
10,525
+15
+0.1% +$562 ﹤0.01% 1763
2018
Q3 		$399K Buy
10,510
+4,010
+62% +$178K ﹤0.01% 2092
2018
Q2 		$294K Sell
6,500
-3,789
-37% -$173K ﹤0.01% 2247
2018
Q1 		$497K Buy
10,289
+2,564
+33% +$143K ﹤0.01% 1721
2017
Q4 		$304K Buy
7,725
+325
+4% +$12.1K ﹤0.01% 2011
2017
Q3 		$230K Buy
+7,400
New +$208K ﹤0.01% 2188
2017
Q2 		– Sell
-6,250
Closed -$230K – 2593
2017
Q1 		$230K Buy
+6,250
New +$157K ﹤0.01% 2055

Other funds holding GBT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Raymond James Financial Services Advisors's GBT Position: Q4 2020 in Review

Raymond James Financial Services Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2020, closing a stake of 4,493 shares — an estimated $248K sold.

Raymond James Financial Services Advisors first reported a position in GBT in Q1 2017 and held it in 14 quarters. The position peaked at $497K in Q1 2018. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

  • Raymond James Financial Services Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 4,493 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $248K.
  • Raymond James Financial Services Advisors first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 14 quarters.
  • Raymond James Financial Services Advisors's Global Blood Therapeutics, Inc. position peaked at $497K in Q1 2018.
  • 228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.